146 related articles for article (PubMed ID: 7835921)
1. Neutralization of transforming growth factor-beta 1 in a mouse model of immune-induced lung fibrosis.
Denis M
Immunology; 1994 Aug; 82(4):584-90. PubMed ID: 7835921
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 (IL-1) is an important cytokine in granulomatous alveolitis.
Denis M
Cell Immunol; 1994 Aug; 157(1):70-80. PubMed ID: 8039254
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.
Zhang K; Gharaee-Kermani M; McGarry B; Remick D; Phan SH
J Immunol; 1997 Jan; 158(2):954-9. PubMed ID: 8993016
[TBL] [Abstract][Full Text] [Related]
4. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
Yamamoto T; Takagawa S; Katayama I; Nishioka K
Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648
[TBL] [Abstract][Full Text] [Related]
5. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis.
Epperly MW; Travis EL; Sikora C; Greenberger JS
Biol Blood Marrow Transplant; 1999; 5(4):204-14. PubMed ID: 10465100
[TBL] [Abstract][Full Text] [Related]
6. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
7. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
8. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
[TBL] [Abstract][Full Text] [Related]
10. Prior SO2 exposure promotes airway inflammation and subepithelial fibrosis following repeated ovalbumin challenge.
Cai C; Xu J; Zhang M; Chen XD; Li L; Wu J; Lai HW; Zhong NS
Clin Exp Allergy; 2008 Oct; 38(10):1680-7. PubMed ID: 18631350
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in bacillus Calmette-Guérin-activated T cells by transforming growth factor-beta.
Méndez-Samperio P; Hernández-Garay M; García-Martínez E
Cell Immunol; 2000 Jun; 202(2):103-12. PubMed ID: 10896770
[TBL] [Abstract][Full Text] [Related]
12. Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice.
Liu JY; Brody AR
J Environ Pathol Toxicol Oncol; 2001; 20(2):97-108. PubMed ID: 11394717
[TBL] [Abstract][Full Text] [Related]
13. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
14. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
McCormick LL; Zhang Y; Tootell E; Gilliam AC
J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model.
Scherf W; Burdach S; Hansen G
Eur J Immunol; 2005 Jan; 35(1):198-206. PubMed ID: 15593298
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation.
Franko AJ; Sharplin J; Ghahary A; Barcellos-Hoff MH
Radiat Res; 1997 Feb; 147(2):245-56. PubMed ID: 9008217
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to bleomycin-induced lung injury is not moderated by an antigen-limited T-cell repertoire.
Thatcher TH; Sime PJ; Barth RK
Exp Lung Res; 2005 Sep; 31(7):685-700. PubMed ID: 16203623
[TBL] [Abstract][Full Text] [Related]
18. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
[TBL] [Abstract][Full Text] [Related]
19. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.
Kolb M; Margetts PJ; Anthony DC; Pitossi F; Gauldie J
J Clin Invest; 2001 Jun; 107(12):1529-36. PubMed ID: 11413160
[TBL] [Abstract][Full Text] [Related]
20. Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Exp Lung Res; 2010 Jun; 36(5):292-301. PubMed ID: 20497024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
